Cellular nucleic acids in serum and plasma as new diagnostic tools

Currently, the diagnosis of bovine spongiform encephalopathy is only possible in the brain stem of dead animals. Protease resistant prions are detected in the obex region of the brain stem. However, from a veterinary medical and agricultural point of view the development of an in vivo detection assay is of utmost importance. Because infectious prions are detectable relatively late in the central nervous system during an infection, efforts are made searching for surrogate markers. Besides neuronal proteins that are released into the liquor and blood during neurodegenerative processes or other neuronal diseases, cellular nucleic acids circulating in the plasma or serum are an absolutely new approach for the detection of infectious diseases.     

Serologic progression studies using CF and ELISA for the detection of antibodies against Eperythrozoon suis infection of swine

Serological studies by means of a CF-Test and Elisa were undertaken for evaluation of antibody titers against Eperythrozoon suis infection in swine. The animals were partly splenectomized and underwent artificial infection. It could be shown that the splenectomized animals showed higher and longer lasting antibody titers than the non splenectomized swine. It is stated, that the above mentioned tests can be used in diagnosis on a herd basis but not on a single animal basis.     

Serological studies of antibodies against maedi-visna virus in sheep in Austria

883 sheep from 68 flocks were tested for the prevalence of antibodies against Maedi/Visna-(M/V)virus. As serological method the Agar Gel Immunodiffusion Test (AGID) was performed, 9.5% of the blood samples were positive against M/V, 1.7% showed questionable results. The highest incidence of serum-antibodies showed the Texel (47.7%) and Milk sheep (26.1%). No antibody titers were found in Mountain and Suffolk sheep. Merino sheep had antibody titers against M/V in 2.6% and Mountain sheep crossbreeds in 1.7%.     

Results of a serological study of the natural spread of maedi-visna virus infection in a sheep herd during an observation period of 30 months

In a sheep population consisting of animals of different breeds the epidemiologic development of the Maedi-Visna-infection was evaluated by means of monthly Immune Diffusion Test (ID) for a period of 30 months. At the beginning the herd consisted of eight animals, where four of them showed clinical symptoms indicative for a MV-infection with positive serological results. The other 4 animals were negative. The herd increased in number by including the offspring and buying in other animals. During the time of 30 months only in one animal a seroconversion could be observed. In nine of 13 lambs borne of seropositive mothers colostral antibodies could be observed. By testing the colostrum of MV-seropositive mothers 6 of 7 animals showed precipitating antibodies. Positive sera showed average titers of 1:2 till 1:64, the highest titer was 1:512. On the postmortal examination of five serological positive animals which were killed because of dominant clinical symptoms, three of them showed MV-lesions partly superinfected with bacteria. In one sheep the diagnosis was pasteurellosis. On a further animal the clinical picture and the histologic results were indicative for the Visna-form of the disease.     

Fluoreszenzmikroskopisch bestimmte mikrobielle Biomasse und deren Beziehung zum Gesamtkohlenstoffgehalt und zur Dehydrogenaseaktivität in ausgewählten Bodenproben

Microbial biomass measured by fluorescence microscopy and its relation to total organic carbon and dehydrogenase activity in selected soil samples Techniques for direct observation of microbial biomass with epifluorescence microscopy, which have proved reliable in aquatic microbiology, were applied for investigation of soils. The procedure for measurement of microbial biomass consisted of ultrasound treatment, filtration with nuclepore-filters, registration of cell-size classes and separate counting of small bacteria. Microbial biomass of an arable A_p (Slu = silty loamy sand) was nearly twice as high with ultrasonication as with untreated samples. In 16 root-free samples removed from different mineral soils, bacterial biomass ranged from 0,22 to 7,50 mg C/g soil, surpassing fungal biomass in general by the factor 2 to 35. Up to 98% of the total organic carbon (C_org) in soil was present in microbial biomass. In uncultivated topsoils dehydrogenase activity was highly correlated with C_org and microbial biomass (n = 7, r_mult. = 0,972, α = 0,001).     

Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole

OBJECTIVES: To evaluate the effectiveness of rhinotomy and surgical debridement associated with topical administration of 2 per cent enilconazole and oral itraconazole in dogs with severe or recurrent sinonasal aspergillosis. METHODS: A standard rhinotomy was performed on seven dogs. In the initial study, the bone flap was left attached cranially and replaced at the end of the procedure. In the main study group, the bone flap was discarded. Nasal passages were debrided and irrigated with enilconazole solution for one hour. Oral itraconazole was administered to four dogs for one month postoperatively. Follow-up rhinoscopy was performed in all dogs. RESULTS: All three dogs in the initial study had recurrence of the disease and two dogs had a second surgery to remove the flap. The main study group included four dogs in which the flap was initially removed, and the two dogs from the initial study that required a second surgery. At follow-up rhinoscopy, five dogs were free of aspergillus but had bacterial or inflammatory rhinitis and one dog had a small aspergilloma but was subsequently asymptomatic. Telephone follow-up revealed that four dogs were asymptomatic, one dog had intermittent sneezing and serous nasal discharge, and one dog had intermittent epistaxis. CLINICAL SIGNIFICANCE: Rhinotomy with removal of the flap combined with one-hour infusion of 2 per cent enilconazole and oral itraconazole resulted in satisfactory outcome in dogs with severe or recurrent aspergillosis.